Theratechnologies Inc. logo

Theratechnologies Inc.

NASDAQ:THTX

Overview | Financials
Company Name Theratechnologies Inc.
Symbol THTX
Currency USD
Price 1.35
Market Cap 62,073,023
Dividend Yield 0%
52-week-range 0.88 - 2.58
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Paul Lévesque
Website https://www.theratech.com

An error occurred while fetching data.

About Theratechnologies Inc.

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and

Related Stocks

Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.

OCUL

9 USD

ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc.

CLPT

12.59 USD

4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.

FDMT

16.25 USD

Verastem, Inc. logo

Verastem, Inc.

VSTM

2.81 USD

Financials

Numbers are in millions USD

Numbers are in millions USD